SINOMAB BIO-B: Interim Report 2024
SINOMAB BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024AND CHANGE IN USE OF PROCEEDS
SINOMAB BIO-B: DATE OF BOARD MEETING
SINOMAB BIO-B: Annual Report 2023
SINOMAB BIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2023;CHANGE IN USE OF PROCEEDS;PROPOSED AMENDMENT TO THE 2022 SHARE OPTION SCHEME; ANDPROPOSED REFRESHMENT OF SCHEME MANDATE LIMIT AND SERVICE PROVIDER SUBLIMIT
SINOMAB BIO-B: DATE OF BOARD MEETING
SINOMAB BIO-B: Interim Report 2023
SINOMAB BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2023
SINOMAB BIO-B: DATE OF BOARD MEETING
SINOMAB BIO-B: Annual Report 2022
SINOMAB BIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2022;CHANGE IN USE OF PROCEEDS;ANDCHANGE OF COMPANY SECRETARY
SINOMAB BIO-B: DATE OF BOARD MEETING
SINOMAB BIO-B: Interim Report 2022
SINOMAB BIO-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2022
SINOMAB BIO-B: DATE OF BOARD MEETING
SINOMAB BIO-B: Annual Report 2021
SINOMAB BIO-B: ANNUAL RESULTS ANNOUNCEMENT FORTHE YEAR ENDED 31 DECEMBER 2021AND CHANGE IN USE OF PROCEEDS
SINOMAB BIO-B: DATE OF BOARD MEETING
SINOMAB BIO-B: Interim Report 2021
SINOMAB BIO-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021
No Data